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ABSTRACT
To empower users of wearable medical devices, it is important to
enable methods that facilitate reflection on previous care to im-
prove future outcomes. In this work, we conducted a two-phase
user-study involving patients, caregivers, and clinicians to under-
stand gaps in current approaches that support reflection and user
needs for new solutions. Our results show that users desire to have
specific summarization metrics, solutions that minimize cognitive ef-
fort, and solutions that enable data integration to support meaningful
reflection on diabetes management. In addition, we developed and
evaluated a visualization called PixelGrid that presents key metrics
in a matrix-based plot. Majority of users (84%) found the matrix-
based approach to be useful for identifying salient patterns related
to certain times and days in blood glucose data. Through our eval-
uation we identified that users desire data visualization solutions
with complementary textual descriptors, concise and flexible presen-
tation, contextually-fitting content, and informative and actionable
insights. Directions for future research on tools that automate pat-
tern discovery, detect abnormalities, and provide recommendations
to improve care were also identified.
CCS CONCEPTS
•Human-centered computing→ User studies; Empirical stud-
ies in HCI .
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1 INTRODUCTION
Diabetes is the 7th leading cause of death in the United States
[12]. It is characterized by impaired glucose metabolism yielding
frequent high and low blood glucose (BG) levels that increase the
risk of long-term macro- and micro-vascular complications [4]. In
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Figure 1: Example of a Continouous Glucose Monitor
(FreeStyle Libre [27]) - Wearable Medical Device.
addition to prescribed medications and/or insulin use, management
of diabetes also benefits from frequent monitoring of BG levels and
a remedy action when blood glucose levels are above or below the
healthy range. Persons on intensive insulin therapy, such as with
Type 1 Diabetes (T1D), are often good candidates for continuous
glucose monitors (CGM) to achieve 24/7 tracking of their BG levels.
Figure 1 shows an example of a CGM worn on the back of a user’s
arm and the blood glucose value at a given time.
CGM use has been shown to improve diabetes management
and reduce adverse events such as hypoglycemia also known as
low blood glcuose [7], [20], [26], [56]. However, a major barrier to
optimal CGM use is in limitations of data delivery and reporting
tools that enable effective interpretation [7], [26]. From the perspec-
tive of a patient or user, self-tracking using CGMs present similar
challenges as other personal health devices including challenges
with data interpretation and application to care [18], [58]. Over the
course of days and weeks, a patient’s CGM dataset grows quickly
and it becomes a challenge to identify salient information from the
large dataset. The American Diabetes Association (ADA) recom-
mends two to fourmedical visits on an annual basis for persons with
diabetes [4]. This translates to an adherent patient visiting with
their healthcare provider every 3 to 6 months. From a physician’s
perspective, it is rather difficult to review, digest, and interpret 3 to
6 months worth of a patient’s CGM data during short clinical visits
(often about 20 minutes long). Therefore, physicians tend to review
only the two most recent weeks of CGM data to assess glucose
management since the last visit [11].
In this paper, we investigate user-needs with respect to decision-
support tools that can facilitate reflection on personal health data
from CGMs to guide and improve future diabetes management
strategy. In addition, we design and evaluate a visualization ap-
proach for CGM data to enable recognition of temporal patterns,
and facilitate introspection on behavior over both short and long
time periods. To achieve our objective, we first conducted a needs
assessment survey to understand: 1) what users focus on when
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they review retrospective blood glucose data? and 2) what users
view as existing gaps in state-of-the-art data presentation tools?
From this study, we identified 3 important things that users of such
personal health data (i.e. patients, caregivers, and clinicians) de-
sire to support meaningful reflection on health, including specific
summarization metrics, solutions that minimize cognitive effort, and
solutions that enable data integration. Specific to diabetes manage-
ment, participants identified specific summarization metrics such
as time-in-range, patterns/trends of highs and lows, average blood
glucose, and trends during certain times/hours/days. Additionally,
users identified gaps in state-of-art data reporting tools for diabetes
care including solutions that automatically extract patterns, detect
changes, and suggest recommendations to mitigate suboptimal out-
comes, and solutions that integrate pertinent data from multiple
sources (e.g. continuous glucose monitors and activity trackers).
Following this, we conducted a 2-phase iterative design and
evaluation of matrix-based visualization scheme which we call Pix-
elGrid. Input from a Phase 1 study was used to revise the design for
further evaluation in Phase 2. A key result is that majority of the
participants (84% across both studies) found PixelGrid useful for
identifying patterns as it relates to certain times/days. A total of 31
patterns were identified across all participants in Phase 2 testing.
Some subjects also found PixelGrid useful in the process of pin-
pointing habits that contribute to management gaps and informing
positive modifications to treatment regimen. Participants also pro-
vided input to further develop decision-support tools for improved
management of diabetes. Given that PixelGrid is a departure from
standard visualization tools used in practice (i.e. daily overlay plots),
both in layout and color scheme, it was expected that participants
encountered some usability challenges considering that they had
no prior training/exposure to new visualization.
Through our design and evaluation process, we identified four
important things that users desire in data visualization tools to
support meaningful reflection on personal health data including,
complementary textual descriptors, concise and flexible presentation,
contextually-fitting content, and informative and actionable insights.
While this paper focuses on diabetes as one application space, we
envision that insights from this study can inform development of
decision-support tools in other domains that benefit from personal
health data. Recent literature shows that there is a surge in research
and development of wearable health monitoring systems [13], [44].
For example, wearable electrocardiograms are becoming preva-
lent for continuous monitoring and treatment of arrhythmia (also
known as irregular heartbeat) and several commercial products
now exist such as iRhythm’s Zio XT [35]. As such wearable medical
devices are becoming commonplace for health monitoring, hence,
data delivery and reporting tools are critical to support reflection
on previous data and improve future outcomes.
2 RELATEDWORK
In this section, we present background and ongoing research on
the topics of personal informatics, data visualization in health, and
decision support in diabetes management.
2.1 Personal Informatics
Personal informatics is the process of building knowledge through
self-logged data for reflection and discovery, to drive change in
activities and behaviors, and to improve health [17], [18], [41], [56],
[59]. In recent years, advancements in wearable and mobile systems
are facilitating the transition from manual tracking to technology-
driven monitoring. Sensors and systems have been developed for
tracking physical activity, food intake, mental health, sleep, and
much more [15], [39], [47], [57]. The value of self-tracking and in-
trospective is well established [8], [59]. Toward designing effective
technology that enables self-reflection, Li et al. [41] identified six
things people want to understand from their personal data includ-
ing: status, history, goals, discrepancies, context, and factors. The
authors also introduced the phases of discovery and maintenance
that a user often transitions to-and-fro, as they set and strive for
goals. Other research supports the importance of designing persua-
sive technology to target various stages that individuals progress
through in the decision-making process of intentionally modifying
or changing a lifestyle behavior [19]. This includes enabling an ap-
propriate balance between technology and the human-in-the-loop
[40].
For persons with ailments (e.g. chronic diseases), personal in-
formatics can be particularly important to support the notion of
patient-centered care in a two-fold way. Firstly, personal informat-
ics can help a patient better understand their health status on a
continuous basis, support self-management, and motivate behavior
change to improve outcomes. Mamykina et al. describe this process
in a sensemaking framework that includes “perception of new infor-
mation related to health and wellness, development of inferences
that inform selection of actions, and carrying out daily activities in
response to new information” [42]. A similar sensemaking frame-
work to inform the design of diabetes decision support systems is
also presented by Katz et al. [37]. Secondly, personal informatics
can contribute to clinical decision-making and treatment plans [5].
For example, self-logged data can "fill in the gap" between doctor
visits [58]. However, many barriers hinder a user (ordinary, patient,
or doctor) from extracting maximum benefit from the wealth of data
that can be acquired through self-logging. Some of these barriers
include time constraints, poor visualization/analytics tools, limited
analytical skills of the average user, and fragmented data across
multiple platforms [6], [18], [40]. Wyatt and Wright [61] highlight
four key difficulties related to interpreting large amounts of health
data, two of which are: 1) comparing within the dataset that is
often spread across pages and sections, and 2) identifying trends.
These barriers inform one of the objectives of this paper which is
to design and evaluate an non-standard approach for visualizing,
interpreting, and extracting clinically-relevant insights from daily
records of CGM data in diabetes management.
2.2 Data Visualization in Health
One of the primary objectives of a visualization is to help people find
valuable insights, where insights can be defined as "an individual
discovery about the data by the participant, a unit of discovery" [50].
According to Choe et al., there are 8 types of visualization insights
including detail, self-reflection, trend, comparison, correlation, data
summary, distribution, and outlier. In practice, visual tools are often
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used and found to be effective as an alternative or supplement to
text-only presentation of health data. Pictorial representations can
be more engaging and enable easier understanding of key details. In
healthcare, data visualization has been used to communicate medi-
cation instructions [33], [38], health risk information [2], treatment
choices [30] and for just-in-time interventions [52]. Earlier work by
Powsner and Tufte’s [46] presented a short but detailed graphical
summary of patient data and status for quick access to the most
relevant information in medical records. The approach did not aim
to replace traditional methods of record-keeping, but to supplement
it in ways that "allow the viewer to assess relations" and consider
alternative management strategies when needed. Other notable
visualization projects on which many variations have been built
include LifeLines [45] and TimeLine [10]. For example, Aigner and
Miksch [1] developed CareVis by employing multiple views (i.e.
logical, temporal, and a quickview panel) to organize and present
patient data. More detailed reviews as it relates to knowledge dis-
covery, information visualization, and challenges in medicine can
be found in [16], [24], and [32]. From the wealth of knowledge
in visualization, a key lesson for developing a useful tool is that
end-users should be involved in the design process from conception
[1], [61].
2.3 Decision Support in Diabetes Management
Given that many daily decisions directly influence diabetes, there is
great interest in methods that can ease the decision making process
for all stakeholders. This includes tools to track and monitor be-
haviors that affect blood glucose, communicate management status,
encourage reflection, and influence treatment plans. A review of
mobile-based self-management applications can be found in the
papers by Arsand et al. [3] and Tatara et al. [54]. Recent work
by Katz et al. suggest that low adoption of diabetes management
applications could be influenced by interfaces failing to address
cognitive and emotional requirements of users [36]. Specific to visu-
alization of diabetes data, Frost and Smith [28], [53] introduced and
evaluated a color-coded grid-format presentation, plotting time-
of-day in the rows versus glucose measurements per day in the
columns. Their tool enabled the user to "zoom in" to particular
days to view a line-graph of glucose measurements with associated
imagery, when present. Similarly, Desai et al. investigated various
visual representations for forecasted post-meal blood glucose for
persons with type 2 diabetes [21] while Feller et al. [25] introduced
Glycolyzer for analyzing the effect of meals on blood glucose mea-
surements. Glycolyzer was developed to contain a heatmap view
of meals versus macronutrient and glycemic impact, meal images
and a summary nutritional content, and probability density plots
of glucose changes in response to nutritional content. This tool
was designed for and evaluated by one stakeholder (i.e. registered
dietitians) in a simulated clinical visit. Unlike many of the afore-
mentioned studies, which rely on sparse blood glucose data from
glucometers with about 4 - 8 measurements per day, our work uses
data from CGMs with up to 288 samples per day.
A limited number of studies have developed tools for use with
CGMdata. Rodbard [48] proposed using stacked bar charts to visual-
ize glucose distribution inmultiple ranges that facilitate comparison
by date, time of day, and day of week. However, the usefulness of
Rodbard’s approach is unknown because their methods were not
evaluated amongst end-users. In practice, a 24-hour (daily) glucose
overlay plot is most commonly used to present CGM data [51]. It is a
2-D time-series plot (BG versus time) included in most download re-
ports by device manufacturers such as Dexcom [22], and Medtronic
[43]. As shown in Figure 2, the daily overlay plot presents 7-days
of data where each trend line represents a different day’s blood
glucose data. Additionally, horizontal lines that run parallel to the
x-axis are used to indicate the target glucose range. Alternatively,
experts within the diabetes community also use the Ambulatory
Glucose Profile (AGP) [7], [20]. A single page report that includes
"summary statistics, a glucose profile graph and an insulin profile
graph or glucose daily calendar graphs" [34]. Both the daily overlay
plot and glucose profile plot in AGP reports are used to present up
to 2-weeks of diabetes data for review and analysis. Unlike these
visuals that graph raw glucose data in a trend or summary plot, in
this paper, we evaluate PixelGrid, a color-based matrix-based plot
with the aim of supporting end-users to identify temporal patterns.
3 METHOD
3.1 Participants
A total of 20 subjects (16 female, 4 male; ages: 19 - 45yrs) partici-
pated in this study approved by the appropriate Institutional Review
Board (IRB). Subjects represented 3 end-user populations (i.e. stake-
holders) including: patients with diabetes who use CGMs for daily
management (n = 11), care-givers of patients with diabetes who
use CGMs for daily management (n = 3), and clinicians of patients
with diabetes who use CGMs for daily management (n = 6). Of the
clinicians who participated in this study, all but one are endocrinol-
ogists with diabetes speciality. Participants were recruited from a
metropolitan area in Texas and online diabetes communities.
3.2 Dataset
We created all visuals for this study using one randomly-selected
subject from a dataset including 60 days of CGM data from 10
persons with T1D. All CGMs recorded at a rate of 1 sample every
5 minutes. Given that CGMs are wearable systems for which the
subject decides if/when to wear it, the amount of data samples per
subject varies depending on thewear time per subject. The complete
dataset includes 152,477 total CGM samples for 10 subjects.
3.3 Design of PixelGrid Visualization
3.3.1 CGM-Metrics for Visual Presentation. An effective visual
analytics tool should enable quick access to key insights of rele-
vance to the viewer. With this in mind, two sources informed the
CGM metrics included in our visualization: 1) diabetes expert panel
recommendations [7] [20] [26], and 2) user input from our needs
assessment survey (section 4.1). We compiled and prioritized key
metrics in the order listed below:
(1) LowWear-Time of CGMs is associatedwith decreased glycemic
control [29], [56], [60]. According to Rodbard [49], "benefit
is proportional to frequency of use." Therefore, low wear-
time, defined in this work as less than 50%, ranked as the
first priority metric to track and display in our visualization.
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Figure 2: Example of the conventional daily overlay plot for data visualization and interpretation of CGM data [22].
Daily glycemic control cannot be quantified when there is
no supporting data of a patient’s blood glucose trends.
(2) Low Blood Glucose is directly associated with acute compli-
cations such as loss of consciousness, seizures, and even
death [4], [7], [23]. Following analysis for data sufficiency,
identifying hypoglycemic (i.e. low blood glucose) events is a
priority. Diabetes experts recommend gradation of low blood
glucose into buckets of low (54 - 70 mg/dL) and very low (< 54
mg/dL) [7], [20]. Therefore, these two metrics were included
in our visualization for quick access by the end-user, with
higher priority given to very low blood glucose because its
consequence is more severe.
(3) High Blood Glucose is associated with long-term vascular
complications [4]. In addition to assessing hypoglycemic
events, decreasing the occurrence and severity of hyper-
glycemic (i.e. high blood glucose) events is a tertiary con-
cern. Similarly, diabetes experts recommend gradation of
high blood glucose into buckets of high (> 180 mg/dL) and
very high (> 250 mg/dL) [7], [20]. Therefore, these two met-
rics were included in our visualization for quick access by
the end-user, with higher priority given to very high blood
glucose because it is more severe.
(4) Time-in-Range is an importantmetric for quantifying glycemic
control in diabetes management. It refers to the percentage
of reading in the target range of 70 - 180 mg/dL [7] [20].
Following analysis of the above suboptimal events, time-
in-range was calculated and categorized as positive when
greater than 70%.
3.3.2 Layout of PixelGrid Visualization. PixelGrid visualization
presents key parameters for evaluating diabetes management in
anm × n matrix-based plot. Prior research highlights the need for
methods of displaying blood glucose data to facilitate comparison
by date, time of day, and day of the week [48]. Therefore, the cho-
sen layout of PixelGrid presents CGM data under the confines of
recurring time-blocks for quick-access pattern recognition. The
layout chosen aims to enable rapid identification of habits and daily
schedules that influence good and/or suboptimal glucose trends.
We developed and evaluated PixelGrid plots for short-term (i.e.
single week) and long-term (i.e. multi-week) assessment of real
CGM datasets. In single-week visualizations, the rows were used to
represent days of the week ranging from Monday to Sunday, while
the columns were used to represent hours of the day ranging from
0 to 24 (i.e. midnight-to-midnight). Row assignments were kept con-
sistent in the multi-week visualization to minimize cognitive load.
However, the columns of multi-week plots were used to represent
user selected weeks for analysis. Figure 3 shows a representative
image of the final (Phase 2) layout of PixelGrid visualization for
single- and multi-week CGM assessment.
Contrasting colors were also used to represent each discrete
parameter that could be of interest to an end-user retrospectively
reviewing a CGM dataset. Prior research [31] identified 3 color-
selection criteria that enable an observer to rapidly and accurately
search a visual, namely, color distance, linear separation, and color
category. Additionally, a comparison study of the trade-off between
the number of colors in a display and response time to identify a
target found that the human visual system can handle up to five
different colors in one image [31]. These results informed the choice
of colors in PixelGrid visualization. The neutral color, white, was
used to represent periods where the CGM contained insufficient
data points for analysis, this is indicative of a user not wearing
their device (i.e. low wear time). Warm colors, namely orange and
yellow, were used to represent very high and high blood glucose,
while, cool colors, namely, dark blue and light blue were used to
represent very low and low blood glucose. The color green was used
to represent periods where the user’s blood glucose was maintained
within the target range (i.e. good diabetes management). Unlike the
work by Desai et al. [21], we avoided using the color red for very
high or very low values as this can elicit fear in users and end up
being more discouraging than encouraging.
4 USER STUDY AND RESULTS
Figure 4 shows an overview of the multi-stage design process. All
participants started by completing an end-user survey tailored for
patient/care-giver versus clinician population. This survey was to
understand needs within a community of stakeholders and for in-
form choices in developing PixelGrid visualization. Five subjects
(3 patients with diabetes and 2 endocrinologists with diabetes spe-
cialty) participated in the concept validation (i.e. Phase 1) user study.
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Figure 3: Layout of PixelGrid visualization of CGM data.
Feedback collected from Phase 1 was used to inform modifications
toward developing an improved visualization that was evaluated in
a second user study. Phase 2 was fully completed by 14 subjects (7
patients with diabetes, 3 care-givers, and 4 clinicians with diabetes
specialty). One subject provided incomplete data resulting in 14
instead of 15 subjects in Phase 2. There was no overlap between
subjects who participated in Phase 1 and Phase 2 user study. In
addition, participants received no training and had no exposure to
PixelGrid visualization prior to participating in this study.
4.1 End-User Needs Assessment Survey
This survey contained two open-ended questions crafted to un-
derstand: 1) what users focus on when they review retrospective
glucose data? and 2) what users view as existing gaps in state-of-
the-art diabetes data reporting tools? All participants were familiar
with CGM reports and had extensive experience (1 to > 10 years)
with daily overlay plots (see Figure 2) for reviewing and reflect-
ing on diabetes-device data. Given this, the below questions were
asked:
4.1.1 When reviewing aCGMreport,what are the top things
you look for in recent management? The top 5 responses that
emerged from participants include: time-in-range (9 mentions), pat-
terns/trends of highs and lows (9 mentions), average blood glucose
(6 mentions), trends during certain times/hours/days (5 mentions),
and time-below-range (4 mentions). These responses are consistent
with key metrics identified by diabetes experts in consensus reports
[7] [20] [26]. Subject 5 (physician) stated that they focus on: 1)
time-in-range, 2) percent in hypoglycemia (< 54mg/dL), and 3) daily
trends. Subject 6 (patient) stated that they look for trends by time of
day, average blood glucose, and trends of high/low activity/stress days.
Other prevalent responses that subjects mentioned include: effect
of activity such as exercise/meal/insulin, glucose spikes/variability
and standard deviation. The visualization presented in this paper
does not encompass all responses, however, it includes majority of
the most prominent responses.
4.1.2 What do you wish CGM reports included that could
help and/or speed up analysis and interpretation of diabetes
management? Two prominent responses emerged from partici-
pants including a desire for CGM reports to: 1) automatically extract
trends/patterns, detect changes in management, and suggest spe-
cific behavior changes (6 mentions), and 2) integrate data from
insulin pumps, bluetooth enabled insulin pens, and carbohydrate
intake (6 mentions). Subject 14 (patient) stated that they wish CGM
reports identified any recent changes in management (for example:
time-in-range has decreased in [the] last week. On the other hand,
subject 15 (patient) stated it would be helpful if it [CGM reports]
were more clear identifying when/where I should be making specific
changes to basal or bolus [insulin] choices. Other prevalent responses
mentioned include: the ability to review more days in the same
graph, identify best/worst days of management to understand what
behaviors to avoid, and not having to upload supplemental data or
manually enter data into reports. Subject 12 (patient) said I wish it
[CGM reports] integrated data from my [insulin] pump without me
having to manually enter it... It would also be cool to know what foods
I ate etc. without manually entering it. It is too tedious to manually
enter it in, therefore I never do it. The visualization presented in this
paper does not encompass all responses, however, it is a building
block toward 3 desires mentioned, namely, automatically extract-
ing trends/patterns, enabling review of multiple days in the same
graph, and identifying the best and worst days of management to
pin-point supporting behaviors.
4.2 Insights for Designing Decision Support
Tools
Themes identified from our needs assessment survey suggest three
key things that users desire to support meaningful reflection on
personal health data, namely:
(1) Specific SummarizationMetrics: Thesemetrics are often famil-
iar quantities that are easy to calculate such as time-in-range
(i.e. a ratio) and average blood glucose (i.e. mean of a set of
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Figure 4: Overview of PixelGrid Design Process
numbers). Additionally, these metrics should be relevant to
quantify "history" and "status" [41] such as patterns/trends of
highs and lows, and trends during certain times/hours/days.
(2) Solutions that Minimize Cognitive Effort: This is evident from
users desire for data reporting tools to "automatically" ex-
tract trends/patterns, detect change in management, and
suggest specific behavior change. The point here is auto-
matic summary of status, identification of recent changes,
and recommendation for improvement.
(3) Solutions that Enable Data Integration: It is not uncommon
for people to use multiple self-tracking devices for their
unique capabilities in today’s society. Therefore, users desire
for solutions that enable integration of personal health data
for multiple sources to support a greater understanding of
interrelated metrics. For example, physical activity has a
direct effect on blood glucose, hence, solutions that support
integration of these data sources would be useful.
5 EVALUATION OF PIXELGRID
The following section reports on a two-phase evaluation of the
proposed PixelGrid visualization described above and insights iden-
tified for designing effective data visualization tools for personal
health data.
5.1 Phase 1: PixelGrid Concept Validation
A remote design platform, UsabilityHub [55], was used to conduct
this concept validation study. Real blood glucose data as described
in section 3.2 was presented using PixelGrid visualization. Figure 5
shows the two PixelGrid images created to depict 1-week (i.e. short-
term) and 1-month (i.e. long-term) CGM data for retrospective
analysis. Subjects reviewed this image while answering 4 open-
ended questions. During this phase, 3 participants were observed
remotely and asked to "think aloud" [14] while a researcher took
notes of pain points not captured in users’ textual response.
Below are the questions and learnings from Phase 1 testing:
5.1.1 Looking at the proposed visualization, what do you
understand from it? The majority of the participants, 4 out of 5
(or 80%), identified salient details of blood glucose readings as it re-
lates to times/days when it was most prominent. Subject 2 (patient)
stated, I can see a pattern of highs from 8am to 10am ... there are also
small patterns of low [blood glucose] after highs when highs occur
after 3pm. Subjects 1 (physician) and 4 (patient) noticed that low
BG episodes mostly occur on Sundays, mid morning to late afternoon.
This connection between key metrics of diabetes management and
time of day/week can support identification of temporal patterns
that negatively or positively influence blood glucose trends. Ac-
cording to subject 3 (patient), this visualization lets you see where
Figure 5: Phase 1 concept validation: PixelGrid visualization
of real CGM dataset
there are clusters of highs and lows and whether they remain fairly
consistent over the course of weeks or months.
5.1.2 What is a scenario where the proposed visualization
might be important? All participants, 5 out of 5 (or 100%), men-
tioned that the PixelGrid visualization is useful for quick identifica-
tion of trends and recurrences that happen during certain days or
hours. As a physician, subject 1 stated that this visualization allows
the reviewer to ask specific and directed questions to the patient about
certain dates or experiences that resulted in glycemic excursions. Sub-
ject 5 (physician) stated, this visualization can help guide diabetes
treatment regimens (insulin doses, exercise, etc). Subject 3 (patient)
stated that this visual might be useful if you want to view a lot of
data over a long period of time but do not want to condense it all into
one trend and end up missing trends throughout the week... The color
blocks are simple and straightforward.
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5.1.3 What do you like about the proposed visualization
tool? Subjects liked that this visualization is: 1) color-based, 2)
enables the user to quickly find patterns and compare data from
different times/days, and 3) does not overlay information on top of
each other (i.e. not cluttered). Subjects 2, 3, and 5, all used the word
easy in their description of what they like. Subject 2 (patient) stated
that PixelGrid visualization is a less-crowded method of seeing multi-
ple days and times in one plot for easy comparison. Subject 3 (patient)
stated that making the data look like blocks makes it easy to look at
where high and low [blood glucose periods] are clustered. I appreciate
how easy it is to compare between weeks. Subject 4 (patient) stated
a similar point, that it is based on color instead of numbers. Graphs
with dips and highs can make it confusing when you’re overlaying
information.
5.1.4 What additional features/changes would you like to
see added to the proposed visualization? Recommendations
mentioned by more than one subject include: 1) adding summary
metrics of patterns in a text-based format to the visual, and 2)
enabling an interactive data visualization tool such that an end-
user can select the dataset to plot and ranges for high/low blood
glucose. Subject 1 (physician) suggested to add percent of time for
each category written in prose alongside the image. Similarly subject
5 (physician) suggested to summarize patterns. The other key point
of an interactive data visualization is supported by subjects 2 and 3.
Subject 2 (patient) stated that it might be useful to do [select] a day
(i.e. a month of all Mondays) and subject 3 (patient) stated maybe a
slider to decrease the range for each group would be helpful so people
who want more information can get it.
5.2 Phase 2: Improved PixelGrid Validation
Figure 6 shows an image of the improved PixelGrid visualization
that was developed and evaluated. In this phase, a new set of 15
subjects were asked open-ended questions about the design. Us-
abilityHub [55] was used for remote testing. This phase did not
include remote observation and the "think aloud" method. Based
on the feedback received from Phase 1, 4 key items were modified
to create the Phase 2 visualization.
Modification 1 Using a single image for long timescale (multi-
week CGM) visualization. This revision was made to reduce
the cognitive load required by an end-user to find patterns
from multiple images. From phase 1 testing, 3 participants,
subjects 1, 2 & 4, mentioned that the 1-month CGM assess-
ment (bottom image in Figure 5) was hard to follow. Subject
1 (physician) stated that it is challenging to see all the data in
the current image [1-month CGM assessment].
Modification 2 Adding summary metrics in a text-based for-
mat to the visual. This feedback was directly mentioned by
2 participants in Phase 1 testing. Subject 5 (physician) stated
in response to suggested changes: summarize patterns, for
example, time of day that CGM user is running high/low. Sim-
ilar to modification 1, it is expected that this change will
reduce the cognitive load required by an end-user to men-
tally calculate summary metrics for quick understanding of
management.
Modification 3 Enabling the end-user’s control of what data
to view in more details. This revision allows the user to select
a specific week to further analyze from the multi-week CGM
assessment plot. From Phase 1 testing, subject 3 (patient)
suggested a change to accommodate for people who want
more information.
Modification 4 Changing x-axis labels from a 24-hour time
convention (less common in the U.S.) to a 12-hour time con-
vention (more common in the U.S.). In Phase 1 testing, sub-
jects 1 (physician) & 2 (patient) identified patterns from Fig-
ure 5 in specific time ranges, however, they used A.M. and
P.M convention to report their observations. This means the
participants likely expended unnecessary efforts to convert
from the 24-hour clock to the 12-hour clock. This change
appeals to the cultural norm and context of users.
Specific questions and learnings from Phase 2 are as follows:
5.2.1 Take a minute to study the proposed PixelGrid visu-
alization, what insights can you draw about the user’s dia-
betesmanagement? The majority of participants, 12 out of 14 (or
85.7%), consistently identified the most prominent insight, which
is that the user has poor management on weekends in the single-
week plot compared to weekdays. Additionally, 7 out of 14 (or 50%)
participants consistently identified a second insight that the user
has a pattern of low BG in the evenings. These are both clinically-
relevant patterns useful to inform future treatment plans. Given the
relevance of these patterns in the underlying data, two participants
recommended a change in treatment regimen during certain time
periods. For example, subject 8 (patient) stated, from the single-
week [CGM assessment plot], it looks like perhaps weekend [insulin]
rates/management could be adjusted... look at changing overnight
basal rates to avoid sleeping low [i.e. low BG during the night]... con-
sider raising basal [insulin] rates in the evening as well, as there seems
to be a pattern for very low BG. A similar comment was made by sub-
ject 18 (physician) who stated that the patient has fair control during
the week, however poor control on weekends. [There are] patterns of
lows in evening, so need to ask if patient is exercising, how much [they
are] eating, etc. to ascertain the reason. Such responses align with
the objective of solutions to support reflection on personal health
data. These responses support that PixelGrid enables end-users to
identify patterns of good and/or poor management from retrospec-
tive CGM data. Additionally, some participants found PixelGrid
useful to guide questioning to identify behaviors associated with
management gaps, and to support treatment regimen changes that
can address future mishaps.
5.2.2 List all of the patterns you see in: [1] PixelGrid "Multi-
weekCGMAssessment" (top) plot, and [2] "Single-weekCGM
Assessment" (bottom) plot. Leave blank if none. A total of 31
patterns were identified by study participants ranging from a mini-
mum of 0 (i.e. blank response) to a maximum of 7 patterns. At least
3 patterns were identified by 7 out of 14 (or 50%) participants. Only
2 subjects (or 14%) left this response blank (i.e. identified 0 patterns).
From the multi-week plot, subject 12 (physician) stated that the user
had poor TIR on Sundays, pretty good [TIR] on Thursdays and Fridays.
[The user’s BG was] most variable on Tuesday and Wednesdays. Week
5 was the best week. Additionally, from the single-week CGM plot,
subject 12 (physician) observed good [CGM] wear time (93% of the
time), higher BG on Saturday and Sunday. More lows [i.e. low BG]
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Figure 6: Phase 2 concept validation: PixelGrid visualization of real CGM dataset
toward the evening. These responses also support that PixelGrid
was useful to most participants for identifying good and suboptimal
patterns in diabetes management.
5.2.3 What do you like or NOT like about the PixelGrid vi-
sualization? There was a consensus on two key points relating
to what participants did not like about PixelGrid. First, it provides
no specific recommendations about what the user can change to
improve their diabetes management. Subject 19 (patient) stated that
they hated the multi-week [CGM assessment plot] because it’s hard to
understand what to change. Similarly, subject 20 (physician) stated
that PixelGrid gives a general pattern but no specifics as to what
needs to be changed. The second area for improvement identified by
participants relates to the choice of colors in PixelGrid visualization.
Subject 12 [physician] stated if there are no detectable patterns, you
[the end-user] will just see random colors which could be frustrating to
a patient [end-user]. Likewise, subject 17 [physician] stated I think
for some, the color flow may be confusing or not intuitive. Another
response for consideration in future work mentioned by subject
16 (physician) is to add more data/details on hypoglycemia (low
BG). On a positive note, subject 18 [physician] stated I do like how I
can visualize overall patterns in ONE screenshot. The above feedback
will be used to inform future work on designing effective decision
support tools for diabetes management.
6 INSIGHTS FOR DESIGNING DATA
VISUALIZATION TOOLS
Themes identified through the design and evaluation of PixelGrid
suggest four key things that users desire in data visualization tools
to support meaningful reflection on personal health data, namely:
(1) Complementary Textual Descriptors: Graphic presentations
alone are not sufficient to support reflection on personal
health data which can be large and multidimensional. There-
fore, effective data visualization tools should include com-
plementary textual descriptors (e.g. summary metrics) of
the visual content. From the concept validation phase of
our design and evaluation process, multiple subjects recom-
mended adding summary metrics in a text-based format to
the graphical presentation to communicate key takeaways.
(2) Concise and Flexible: Users desired to have a minimum num-
ber of visuals and content in a single-view. However, they
also desired flexibility with regards to what content can be
viewed. For example, in the first phase of our study, subjects
2 and 3 alluded to enabling user control "so people who want
more information can get it." Such flexibility can be provided
with an interactive as opposed to static solution.
(3) Contextually-Fitting: The format for data reporting should be
tailored to fit the contextual norm of user populations. For
example, users in this study preferred to see the timescale
reported using a 12-hour clock (i.e. A.M. and P.M.) instead of
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a 24-hour clock, however this preference could be reversed
for users in a different culture or setting where a 24-hour
clock is the standard.
(4) Informative and Actionable: Effective data visualization tools
should be both informative and actionable as one without the
other provides little value to users. In our study, users that
identified actionable insights from information presented
using PixelGrid rated the visualization more positively while
users who found PixelGrid to be informative but not action-
able rated the visualization more negatively.
7 SUMMARY AND DISCUSSION
In this paper, we strive to understand reflection needs of users of
wearable medical devices, one of which is a continuous glucose
monitor used in diabetes management. To learn insights of real end-
users, we included patients with T1D, care-givers, and clinicians
in our multi-stage study. From our needs assessment survey, we
identified 3 important things that users desire from decision sup-
port tools to support meaningful reflection on personal health data.
Firstly, users desired to have specific summarization metrics that
are familiar quantities and easy to understand. Specific to diabetes
management the top 5 evaluation metrics desired were time-in-
range, patterns/trends of highs and lows, average blood glucose,
trends during certain times/hours/days, and time-below-range. Ad-
ditionally, users desired solutions that minimize cognitive effort and
solutions that enable data integration, both of which were evident at
various points in our study. For example, the most prominent items
that emerged from user’s wish lists are solutions that automatically
extract trend/patterns, detect changes in management, and suggest
behavior changes. The other wish list item that ranked high was
for solutions that can integrate pertinent data from multiple de-
vices. These insights are critical to consider and incorporate in the
design of effective design support tools that facilitate reflection on
previous health to inform and improve outcomes.
Following this, we developed and evaluated a data visualiza-
tion tool with the objective of enabling users to quickly and easily
identify temporal patterns in diabetes management. Our proposed
visualization takes a non-conventional approach compared to what
is used in practice (i.e. daily overlay plots shown in Figure 2). The
PixelGrid approach presents blood glucose data in the various cate-
gories of interest (e.g. high, normal, low, etc.) using a color-based
matrix plot. From the evaluation, we found that majority of users
(84% across 2 studies) found it useful for identifying salient patterns
as it relates to times/days in blood glucose data. A few subjects also
found PixelGrid useful to pin-point habits that contribute to man-
agement gaps, and to inform positive modifications to treatment
regimen. For example, subject 18 (physician) stated some questions
they would ask to identify factors influencing a management gap
when they mentioned: there are patterns of lows in the evening, so
need to ask if patient is exercising, how much [they are] eating, etc. to
ascertain the reason. Meanwhile, subject 8 (patient) recommended
2 changes to treatment regimen by stating: from the single week
CGM assessment plot... look at changing overnight basal rates to avoid
sleeping low [i.e. low BG during the night]... consider raising basal
[insulin] rates in the evening as well, as there seems to be a pattern
for very low BG. These results are in alignment with the primary
objective of developing solutions that support reflection to enable
users learn from past data to inform future decisions.
We found that most participants liked the color-coded matrix-
based layout for visualization. For example, subject 2 (patient) stated
that PixelGrid is a less-crowded method of seeing multiple days and
times in one plot for easy comparison, while subject 3 (patient) stated
making the data look like blocks makes it easy to look at where high
and low [blood glucose periods] are clustered. However, subject 12
(physician) identified a potential drawback of this presentation
style which is that when there are no prominent patterns/clusters,
the visual can become busy with many seemingly random colors.
Further research is needed to identify an appropriate solution to this
problem by carefully selecting the color choices and expanding the
research to include automatic pattern recognition to guide users to
relevant insights. A key take-away is that participants appreciated
a summary visual of long-term data in single view, however they
also wanted explicit text-based summary of the content as was
learned from feedback received in the Phase 1 user study.
Through our two-phase design and evaluation process, we iden-
tified four important things that users desire in data visualization
tools to support meaningful reflection on personal health data. Our
findings show that users desire complementary textual descriptors
to support visual content, concise and flexible presentation that
support user control of what is in view, contextually-fitting descrip-
tors that match what is familiar, and informative and actionable
insights that identify what to change. In today’s society, where
personal health data is consistently growing, there is a critical need
for understanding the needs of users and designing technology
that can meet those needs. Wearable medical devices are becoming
prominent for continuous monitoring of other health conditions.
For example, wearable electrocardiograms such as iRhythm’s Zio
XT [35], are useful for continuous monitoring of arrhythmia. In the
aforementioned example and beyond, solutions that support users
with reflecting on personal health data will play a critical role in
maximizing the benefit of these information sources.
7.0.1 Limitations. This work has a number of limitations that
should be addressed in future studies. One limitation is that in
this work we did not show subjects a comparison using an existing
visualization method. This choice was made because majority of our
subjects (18 out of 20) were experienced users with 1 to more than
10 years of experience using the conventional daily overlay plot
for interpretation of CGM data. Meanwhile, all users received no
training and had no prior exposure to the presented visual tool used
in this work. We believe the newness factor would have affected a
fair comparison. However, subjects inherently compared PixelGrid
to what they were familiar with and this is evident through their
responses presented above.
A second limitation is that based on the current design, Pixel-
Grid presents data from a singular outcome variable (i.e. blood
glucose) for retrospective analysis. However, it is known that users
would find increased benefit in a tool that analyzes and presents
insights from individual and related parameters including med-
ication/insulin, food intake, activity, and even sleep. Brown [9]
presents a more comprehensive list of factors that affect blood
glucose, many of which should be considered for monitoring and
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reporting to inform decision making in diabetes management. Re-
sponses from our end-user needs survey support the direction of
integrating data from multiple sources. For example, subject 12 (pa-
tient) said I wish it [CGM reports] integrated data from my [insulin]
pump... It would also be cool to know what food I ate etc. without
manually entering it.
Additionally, this work used a static visual platform to conduct
user studies. Previous research [10], [61] and learnings from the
Phase 1 concept validation study suggests that end-users desire an
interactive system which allows for data manipulation and control
of the content/level of detail presented. Our attempt to show an
interactive visual (e.g. the user selecting week 2 for review in Fig. 6)
on a static platform was missed by most participants. Furthermore,
we did not enforce the use of any given platform during participa-
tion in our study, hence it is unclear how the platform used affected
a user’s experience. We observed that some subjects completed the
study on their mobile device which was not ideal for looking at
the visual while responding to related question. Succeeding studies
will standardize the platforms used to eliminate this inconsistency.
8 FUTUREWORK
This paper is a launchpad for further research on decision support
tools for diabetes management. Our developed solution was effec-
tive with enabling participants easily identify recurrent patterns
present in the underlying blood glucose data. However, there is still
room for improvement. Given the learnings from this study and
desires of stakeholders (patients, care-givers, and clinicians), future
work includes:
(1) Automatic detection of bio-behavioral patterns in diabetes
data to identify connections between blood glucose outcomes
and the context in which they occur. This will in turn reduce
the cognitive load required by end-users to manually identify
patterns from large and continuously growing datasets.
(2) Evaluate the feasibility and accuracy of a recommendation
system that provides specific suggestions based on retrospec-
tive data and patterns regarding what user can change to
improve their diabetes management.
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